IBDEI09S ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12945,1,5,0)
 ;;=5^Organic Brain Syndrome
 ;;^UTILITY(U,$J,358.3,12945,2)
 ;;=^123952
 ;;^UTILITY(U,$J,358.3,12946,0)
 ;;=332.0^^86^780^27
 ;;^UTILITY(U,$J,358.3,12946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12946,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,12946,1,5,0)
 ;;=5^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,12946,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,12947,0)
 ;;=250.60^^86^780^28
 ;;^UTILITY(U,$J,358.3,12947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12947,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,12947,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,12947,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,12948,0)
 ;;=356.9^^86^780^30
 ;;^UTILITY(U,$J,358.3,12948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12948,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,12948,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,12948,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,12949,0)
 ;;=780.2^^86^780^38
 ;;^UTILITY(U,$J,358.3,12949,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12949,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,12949,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,12949,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,12950,0)
 ;;=724.3^^86^780^34
 ;;^UTILITY(U,$J,358.3,12950,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12950,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,12950,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,12950,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,12951,0)
 ;;=780.39^^86^780^36
 ;;^UTILITY(U,$J,358.3,12951,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12951,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,12951,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,12951,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,12952,0)
 ;;=782.0^^86^780^26
 ;;^UTILITY(U,$J,358.3,12952,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12952,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,12952,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,12952,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,12953,0)
 ;;=435.9^^86^780^40
 ;;^UTILITY(U,$J,358.3,12953,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12953,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,12953,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,12953,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,12954,0)
 ;;=354.2^^86^780^42
 ;;^UTILITY(U,$J,358.3,12954,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12954,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,12954,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,12954,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,12955,0)
 ;;=729.1^^86^780^18
 ;;^UTILITY(U,$J,358.3,12955,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12955,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,12955,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,12955,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,12956,0)
 ;;=438.20^^86^780^7
 ;;^UTILITY(U,$J,358.3,12956,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12956,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,12956,1,5,0)
 ;;=5^CVA with Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,12956,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,12957,0)
 ;;=438.12^^86^780^6
 ;;^UTILITY(U,$J,358.3,12957,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12957,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,12957,1,5,0)
 ;;=5^CVA with Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,12957,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,12958,0)
 ;;=356.8^^86^780^29
 ;;^UTILITY(U,$J,358.3,12958,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12958,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,12958,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,12958,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,12959,0)
 ;;=337.20^^86^780^32
 ;;^UTILITY(U,$J,358.3,12959,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12959,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,12959,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,12959,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,12960,0)
 ;;=294.8^^86^780^15
 ;;^UTILITY(U,$J,358.3,12960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12960,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,12960,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,12960,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,12961,0)
 ;;=438.6^^86^780^4
 ;;^UTILITY(U,$J,358.3,12961,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12961,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,12961,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,12961,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,12962,0)
 ;;=438.7^^86^780^5
 ;;^UTILITY(U,$J,358.3,12962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12962,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,12962,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,12962,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,12963,0)
 ;;=438.84^^86^780^3
 ;;^UTILITY(U,$J,358.3,12963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12963,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,12963,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,12963,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,12964,0)
 ;;=434.91^^86^780^8
 ;;^UTILITY(U,$J,358.3,12964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12964,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,12964,1,5,0)
 ;;=5^CVA, Acute Onset
 ;;^UTILITY(U,$J,358.3,12964,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,12965,0)
 ;;=333.94^^86^780^33
 ;;^UTILITY(U,$J,358.3,12965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12965,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,12965,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,12965,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,12966,0)
 ;;=345.90^^86^780^35
 ;;^UTILITY(U,$J,358.3,12966,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12966,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,12966,1,5,0)
 ;;=5^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,12966,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,12967,0)
 ;;=305.01^^86^781^10
 ;;^UTILITY(U,$J,358.3,12967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12967,1,4,0)
 ;;=4^305.01
 ;;^UTILITY(U,$J,358.3,12967,1,5,0)
 ;;=5^Etoh Abuse-Continuous
 ;;^UTILITY(U,$J,358.3,12967,2)
 ;;=^268228
 ;;^UTILITY(U,$J,358.3,12968,0)
 ;;=305.02^^86^781^1
 ;;^UTILITY(U,$J,358.3,12968,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12968,1,4,0)
 ;;=4^305.02
 ;;^UTILITY(U,$J,358.3,12968,1,5,0)
 ;;=5^Alcohol Abuse-Episodic
 ;;^UTILITY(U,$J,358.3,12968,2)
 ;;=^268229
 ;;^UTILITY(U,$J,358.3,12969,0)
 ;;=305.03^^86^781^2
 ;;^UTILITY(U,$J,358.3,12969,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12969,1,4,0)
 ;;=4^305.03
 ;;^UTILITY(U,$J,358.3,12969,1,5,0)
 ;;=5^Alcohol Abuse-In Remiss
 ;;^UTILITY(U,$J,358.3,12969,2)
 ;;=^268230
 ;;^UTILITY(U,$J,358.3,12970,0)
 ;;=303.90^^86^781^11
 ;;^UTILITY(U,$J,358.3,12970,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12970,1,4,0)
 ;;=4^303.90
 ;;^UTILITY(U,$J,358.3,12970,1,5,0)
 ;;=5^Etoh Dependence
 ;;^UTILITY(U,$J,358.3,12970,2)
 ;;=^268187
 ;;^UTILITY(U,$J,358.3,12971,0)
 ;;=300.00^^86^781^3
 ;;^UTILITY(U,$J,358.3,12971,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12971,1,4,0)
 ;;=4^300.00
 ;;^UTILITY(U,$J,358.3,12971,1,5,0)
 ;;=5^Anxiety
 ;;^UTILITY(U,$J,358.3,12971,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,12972,0)
 ;;=296.7^^86^781^4
 ;;^UTILITY(U,$J,358.3,12972,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12972,1,4,0)
 ;;=4^296.7
 ;;^UTILITY(U,$J,358.3,12972,1,5,0)
 ;;=5^Bipolar Affective Disorder
 ;;^UTILITY(U,$J,358.3,12972,2)
 ;;=^14793
 ;;^UTILITY(U,$J,358.3,12973,0)
 ;;=304.20^^86^781^5
 ;;^UTILITY(U,$J,358.3,12973,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12973,1,4,0)
 ;;=4^304.20
 ;;^UTILITY(U,$J,358.3,12973,1,5,0)
 ;;=5^Cocaine Dependence
 ;;^UTILITY(U,$J,358.3,12973,2)
 ;;=^25599
 ;;^UTILITY(U,$J,358.3,12974,0)
 ;;=294.11^^86^781^6
 ;;^UTILITY(U,$J,358.3,12974,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12974,1,4,0)
 ;;=4^294.11
 ;;^UTILITY(U,$J,358.3,12974,1,5,0)
 ;;=5^Dementia W/Behav Disturb
 ;;^UTILITY(U,$J,358.3,12974,2)
 ;;=^321982
 ;;^UTILITY(U,$J,358.3,12975,0)
 ;;=294.10^^86^781^7
 ;;^UTILITY(U,$J,358.3,12975,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12975,1,4,0)
 ;;=4^294.10
 ;;^UTILITY(U,$J,358.3,12975,1,5,0)
 ;;=5^Dementia W/O Behav Disturb
 ;;^UTILITY(U,$J,358.3,12975,2)
 ;;=^321980
 ;;^UTILITY(U,$J,358.3,12976,0)
 ;;=311.^^86^781^8
 ;;^UTILITY(U,$J,358.3,12976,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12976,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,12976,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,12976,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,12977,0)
 ;;=309.0^^86^781^9
 ;;^UTILITY(U,$J,358.3,12977,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12977,1,4,0)
 ;;=4^309.0
 ;;^UTILITY(U,$J,358.3,12977,1,5,0)
 ;;=5^Depressive Reaction, Brief
 ;;^UTILITY(U,$J,358.3,12977,2)
 ;;=^3308
 ;;^UTILITY(U,$J,358.3,12978,0)
 ;;=305.50^^86^781^12
 ;;^UTILITY(U,$J,358.3,12978,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12978,1,4,0)
 ;;=4^305.50
 ;;^UTILITY(U,$J,358.3,12978,1,5,0)
 ;;=5^IV Drug Use
 ;;^UTILITY(U,$J,358.3,12978,2)
 ;;=^85868
 ;;^UTILITY(U,$J,358.3,12979,0)
 ;;=302.72^^86^781^13
 ;;^UTILITY(U,$J,358.3,12979,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12979,1,4,0)
 ;;=4^302.72
 ;;^UTILITY(U,$J,358.3,12979,1,5,0)
 ;;=5^Inhibited Sex Excitement(Not Organic Impotence)
 ;;^UTILITY(U,$J,358.3,12979,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,12980,0)
 ;;=780.52^^86^781^14
 ;;^UTILITY(U,$J,358.3,12980,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12980,1,4,0)
 ;;=4^780.52
 ;;^UTILITY(U,$J,358.3,12980,1,5,0)
 ;;=5^Insomnia
 ;;^UTILITY(U,$J,358.3,12980,2)
 ;;=^87662
 ;;^UTILITY(U,$J,358.3,12981,0)
 ;;=300.3^^86^781^15
 ;;^UTILITY(U,$J,358.3,12981,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12981,1,4,0)
 ;;=4^300.3
 ;;^UTILITY(U,$J,358.3,12981,1,5,0)
 ;;=5^Obsessive-Compulsive
 ;;^UTILITY(U,$J,358.3,12981,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,12982,0)
 ;;=304.00^^86^781^16
